OR WAIT null SECS
Better coordination in development and review of vaccines is needed.
Advances in technology are accelerating the development and manufacture of subunit vaccines.
Contract manufacturers play a key role in the production of lipid nanoparticles for RNA vaccines.
March 16, 2022
EMA has recommended that possible side effects of Spikevax and Janssen COVID-19 vaccines be added to product information.
March 09, 2022
New technologies are treatments are emerging to tackle COVID-19 and its assortment of new variants.
March 08, 2022
Johnson & Johnson have announced a landmark agreement to enable the manufacturing and availability of its COVID-19 vaccine in Africa by an African company.
Moderna has announced that it has entered a Memorandum of Understanding with the government of the Republic of Kenya to establish its first mRNA manufacturing facility in Africa.
March 04, 2022
Evonik has increased its global supply of plant-derived cholesterol used for mRNA vaccines and gene therapies.
March 01, 2022
FDA has revised the Emergency Use Authorization for sotrovimab.
February 28, 2022
EMA has recommended approval of Spikevax for children aged 6 to 11.
Pfizer and BioNTech receive positive opinion for COVID-19 vaccine booster in adolescents 12 through 17 years of age in the EU.
February 24, 2022
Medicago and GSK have announced that Health Canada has approved COVIFENZ, an adjuvanted plant-based COVID-19 vaccine.
February 23, 2022
Alvea has begun preclinical testing of a scalable, shelf-stable DNA vaccine against SARS-CoV-2 variants.